Sulzer Chemtech Separation Technology Accelerates the Fight Against COVID-19

Rapid Response to Global Healthcare Demands

Sulzer Chemtech is partnering with Farmhispania Group to significantly increase production of a critical drug proven effective in treating critically ill COVID-19 patients. This collaboration enables the pharmaceutical manufacturer to meet surging global healthcare needs for this vital medication.

High-Performance Extraction Technology

The key to intensifying production swiftly lies in Sulzer’s agitated Kühni column (ECR) for liquid-liquid extraction. This advanced separation technology is perfectly suited to the urgent demands of pharmaceutical manufacturing, especially when expanding physical production capacity is not feasible.

Addressing Production Challenges

Pharmaceutical companies face unprecedented pressure to scale up production of medications such as antimalarials, immunosuppressants, and HIV treatments—many of which are currently among the most promising options for hospitalized coronavirus patients. Farmhispania, a leading ingredient manufacturer, has teamed up with Sulzer to overcome these challenges and deliver more life-saving medicines in less than two weeks.

Fast-Tracked Delivery and Installation

Sulzer’s ECR technology stands out for its ability to handle high flow rates, maximizing throughput and efficiency. To ensure rapid deployment, Sulzer leveraged its available stock to build and ship the ECR immediately after the contract was awarded—even delivering over the weekend. Sulzer’s experts are also supporting installation and start-up to get production ramped up as quickly as possible.

Industry Leaders Share Their Perspectives

Dr. Jordi Cervelló Pagès, Industrial Director at Farmhispania Group, comments:

“The exceptional circumstances presented by COVID-19 require pharmaceutical manufacturers to act with great urgency in the interest of public health. Sulzer’s technology and comprehensive service will enable us to significantly expand our operations in a very short time, supporting the recovery of critically ill coronavirus patients in intensive care units worldwide.”

Torsten Wintergerste, Division President for Sulzer Chemtech, adds:

“We couldn’t be prouder to help Farmhispania. I am extremely grateful to our Sulzer staff, who quickly mobilized to deliver the ECR within days. As soon as our teams realized the project would support the fight against coronavirus, they immediately showed their commitment to go the extra mile. Sulzer is ready to support pharmaceutical businesses in these challenging times—we invite those in similar situations to get in touch.”

Want to accelerate your pharmaceutical production with advanced separation technology?

Contact us today to learn how Sulzer Chemtech can help you meet urgent healthcare demands!